Akorn Company Profile (NASDAQ:AKRX)

About Akorn

Akorn logoAkorn Inc. (Akorn), together with its wholly owned subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products. The Company specializes in sterile and non-sterile dosage forms, including ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. The Company operates in two segments: Prescription Pharmaceuticals, which is engaged in the sale of branded and generic prescription pharmaceuticals, and Consumer Health, which is engaged in the sale of branded and private label consumer and animal health products. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: AKRX
  • CUSIP: 00972810
Key Metrics:
  • Previous Close: $26.73
  • 50 Day Moving Average: $31.00
  • 200 Day Moving Average: $27.69
  • Trailing P/E Ratio: 18.10
  • Foreward P/E Ratio: 12.21
  • P/E Growth: 1.53
  • Market Cap: $3.39B
  • Outstanding Shares: 126,029,000
  • Beta: 0.86
Additional Links:
Companies Related to Akorn:

Analyst Ratings

Consensus Ratings for Akorn (NASDAQ:AKRX) (?)
Ratings Breakdown: 7 Hold Ratings, 9 Buy Ratings
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $34.93 (30.03% upside)

Analysts' Ratings History for Akorn (NASDAQ:AKRX)
DateFirmActionRatingPrice TargetDetails
8/5/2016WallachBeth CapitalBoost Price TargetBuy$39.00 -> $40.00View Rating Details
8/5/2016JPMorgan Chase & Co.Set Price TargetBuy$45.00View Rating Details
8/5/2016Deutsche Bank AGDowngradeBuy -> Hold$33.00 -> $33.00View Rating Details
8/2/2016Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
8/2/2016Citigroup Inc.DowngradeMarket Perform$33.80 -> $34.00View Rating Details
7/28/2016RBC Capital MarketsReiterated RatingOutperform$37.00View Rating Details
7/18/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details
5/26/2016Leerink SwannReiterated RatingHoldView Rating Details
5/17/2016GuggenheimReiterated RatingBuy$40.00View Rating Details
5/11/2016Jefferies GroupReiterated RatingBuy$35.00View Rating Details
3/22/2016Craig HallumReiterated RatingBuyView Rating Details
3/23/2016Piper Jaffray Cos.Reiterated RatingHoldView Rating Details
3/23/2016SusquehannaLower Price TargetNeutral$32.00 -> $30.00View Rating Details
3/23/2016William BlairReiterated RatingOutperform$58.00 -> $36.00View Rating Details
3/22/2016S&P Equity ResearchLower Price Target$25.98 -> $21.97View Rating Details
3/21/2016NomuraLower Price TargetBuy$46.00 -> $42.00View Rating Details
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details
3/27/2015Avondale PartnersInitiated CoverageOutperform$56.00View Rating Details
2/27/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details
2/4/2015Sterne Agee CRTInitiated CoverageBuy$52.00View Rating Details
11/13/2014CRT CapitalUpgradeFair Value -> Buy$46.00View Rating Details
(Data available from 8/28/2014 forward)


Earnings History for Akorn (NASDAQ:AKRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216$0.55$0.58$272.99 million$280.70 millionViewListenView Earnings Details
5/16/2016Q116$0.43$0.54$268.00 millionViewListenView Earnings Details
2/26/2015Q414$0.45$0.50$218.87 million$227.80 millionViewListenView Earnings Details
11/6/2014Q314$0.25$0.27$155.20 million$132.70 millionViewListenView Earnings Details
8/5/2014Q214$0.20$0.25$145.16 million$150.70 millionViewListenView Earnings Details
5/6/2014Q114$0.15$0.16$91.44 million$90.60 millionViewN/AView Earnings Details
3/3/2014Q413$0.14$0.14$83.37 million$85.00 millionViewN/AView Earnings Details
11/5/2013Q313$0.14$0.15$80.43 million$81.90 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.13$0.14$75.06 million$77.00 millionViewN/AView Earnings Details
5/7/2013Q1 2013$0.14$0.13$74.07 million$73.90 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.12$0.13$69.42 million$71.50 millionViewN/AView Earnings Details
11/6/2012Q312$0.13$0.12$69.59 million$69.60 millionViewN/AView Earnings Details
8/7/2012$0.12$0.12ViewN/AView Earnings Details
5/8/2012$0.12$0.13ViewN/AView Earnings Details
3/6/2012$0.09$0.11ViewN/AView Earnings Details
11/1/2011$0.06$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Akorn (NASDAQ:AKRX)
Current Year EPS Consensus Estimate: $2.1 EPS
Next Year EPS Consensus Estimate: $2.2 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.50$0.50$0.50
Q2 20162$0.47$0.53$0.50
Q3 20161$0.53$0.53$0.53
Q4 20161$0.52$0.52$0.52
(Data provided by Zacks Investment Research)


Dividend History for Akorn (NASDAQ:AKRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Akorn (NASDAQ:AKRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Kenneth AbramowitzDirectorSell2,691$30.44$81,914.04View SEC Filing  
6/14/2016Joseph BonaccorsiSVPSell6,500$29.84$193,960.00View SEC Filing  
6/10/2016Kenneth AbramowitzDirectorSell14,675$30.16$442,598.00View SEC Filing  
6/9/2016Bruce KutinskyCOOSell142,000$31.12$4,419,040.00View SEC Filing  
6/7/2016Ronald M JohnsonDirectorSell7,542$31.49$237,497.58View SEC Filing  
6/6/2016Kenneth AbramowitzDirectorSell10,900$31.37$341,933.00View SEC Filing  
6/3/2016Joseph BonaccorsiSVPSell90,250$31.23$2,818,507.50View SEC Filing  
6/2/2016Alan D WeinsteinDirectorSell50,000$30.93$1,546,500.00View SEC Filing  
4/21/2015Mark M SilverbergVPSell29,000$55.00$1,595,000.00View SEC Filing  
3/10/2015John N KapoorDirectorBuy19,000$44.26$840,940.00View SEC Filing  
3/3/2015Rajat RaiCEOBuy5,000$47.70$238,500.00View SEC Filing  
2/18/2015Joseph BonaccorsiInsiderSell40,827$47.33$1,932,341.91View SEC Filing  
2/10/2015Ronald M JohnsonDirectorSell17,173$46.44$797,514.12View SEC Filing  
1/26/2015Rajat RaiCEOSell873,985$41.89$36,611,231.65View SEC Filing  
1/12/2015Mark M SilverbergVPSell38,602$41.00$1,582,682.00View SEC Filing  
1/9/2015Ronald M JohnsonDirectorSell17,173$40.46$694,819.58View SEC Filing  
1/2/2015Ronald M JohnsonDirectorSell14,300$36.12$516,516.00View SEC Filing  
1/2/2015Timothy A DickCFOSell30,150$36.03$1,086,304.50View SEC Filing  
12/15/2014Brian TambiDirectorSell1,200$41.86$50,232.00View SEC Filing  
12/12/2014Adrienne L GravesDirectorSell9,557$41.09$392,697.13View SEC Filing  
12/11/2014John N KapoorDirectorSell50,000$41.19$2,059,500.00View SEC Filing  
12/9/2014John R SabatVPSell43,173$40.53$1,749,801.69View SEC Filing  
12/1/2014Timothy A DickCFOSell30,875$39.23$1,211,226.25View SEC Filing  
11/3/2014Timothy A DickCFOSell122,222$44.08$5,387,545.76View SEC Filing  
10/1/2014Timothy A DickCFOSell122,222$35.24$4,307,103.28View SEC Filing  
9/12/2014Brian TambiDirectorSell13,800$38.00$524,400.00View SEC Filing  
9/11/2014Joseph BonaccorsiInsiderSell116,800$37.89$4,425,552.00View SEC Filing  
9/8/2014Kenneth AbramowitzDirectorSell4,500$36.54$164,430.00View SEC Filing  
9/8/2014Rajat RaiCEOSell147,000$36.78$5,406,660.00View SEC Filing  
9/8/2014Timothy A DickCFOSell45,000$37.61$1,692,450.00View SEC Filing  
9/4/2014Alan D WeinsteinDirectorSell5,000$38.49$192,450.00View SEC Filing  
8/26/2014John N KapoorDirectorSell50,000$38.99$1,949,500.00View SEC Filing  
8/7/2014Rajat RaiCEOSell903,659$33.62$30,381,015.58View SEC Filing  
6/13/2014Brian TambiDirectorBuy1,000$27.62$27,620.00View SEC Filing  
5/16/2014Rajat RaiCEOBuy5,000$26.76$133,800.00View SEC Filing  
5/14/2014Kenneth AbramowitzDirectorSell2,557$26.79$68,502.03View SEC Filing  
12/9/2013Alan WeinsteinDirectorSell20,000$25.52$510,400.00View SEC Filing  
12/3/2013Kenneth AbramowitzDirectorSell5,000$25.35$126,750.00View SEC Filing  
12/12/2012Alan D WeinsteinDirectorBuy30,500$13.67$416,935.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Akorn (NASDAQ:AKRX)
seekingalpha.com logoAkorn - Time To Consider Again At Levels In The Mid-Twenties (NASDAQ:AKRX)
seekingalpha.com - August 27 at 8:11 AM
News IconStocks Roundup: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Akorn, Inc. (NASDAQ:AKRX) - NYSE Journal (press release) (NASDAQ:AKRX)
stockznews.com - August 26 at 11:33 AM
News IconInvestor's Watch List: TG Therapeutics Inc (NASDAQ:TGTX), Akorn, Inc. (NASDAQ:AKRX) - NYSE Journal (press release) (NASDAQ:AKRX)
stockznews.com - August 25 at 8:49 PM
forbes.com logoRelative Strength Alert For Akorn (NASDAQ:AKRX)
www.forbes.com - August 25 at 5:58 PM
News IconMovers to Watch – Pernix Therapeutics Holdings (NASDAQ:PTX ... - Money News (press release) (NASDAQ:AKRX)
www.newsismoney.com - August 25 at 3:25 PM
News IconStocks Attracts Frontline Trades- Akorn, Inc. (NASDAQ:AKRX), Medtronic plc (NYSE:MDT) - Seneca Globe (NASDAQ:AKRX)
www.senecaglobe.com - August 25 at 3:25 PM
finance.yahoo.com logo8:34 am Akorn relaunches Ofloxacin Otic Solution 0.3% for otic use (NASDAQ:AKRX)
finance.yahoo.com - August 25 at 3:25 PM
biz.yahoo.com logoAKORN INC Files SEC form 8-K, Regulation FD Disclosure (NASDAQ:AKRX)
biz.yahoo.com - August 25 at 3:25 PM
publicnow.com logoAkorn Relaunches Ofloxacin Otic Solution (NASDAQ:AKRX)
www.publicnow.com - August 25 at 3:25 PM
nasdaq.com logoAkorn Breaks Below 200-Day Moving Average - Notable for AKRX - Nasdaq (NASDAQ:AKRX)
www.nasdaq.com - August 25 at 8:12 AM
thestreet.com logo'Mad Money' Lightning Round: Take Nucor Over U.S. Steel (NASDAQ:AKRX)
www.thestreet.com - August 24 at 11:41 AM
finance.yahoo.com logoAkorn to Present at Morgan Stanley Global Healthcare Conference (NASDAQ:AKRX)
finance.yahoo.com - August 24 at 11:41 AM
News IconStock Gaining Over the Past Six Months: Akorn, Inc. (NASDAQ:AKRX) - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - August 22 at 8:12 AM
marketrealist.com logoWhat Are Analysts Recommending for Teva Pharmaceutical in 2016? (NASDAQ:AKRX)
marketrealist.com - August 19 at 11:48 AM
nasdaq.com logoAkorn Appoints Robert Monahan as Senior Vice President of Corporate Development (NASDAQ:AKRX)
www.nasdaq.com - August 18 at 11:48 AM
marketrealist.com logoWhat Are Analysts’ Recommendations for Mylan and Its Peers? (NASDAQ:AKRX)
marketrealist.com - August 17 at 3:26 PM
finance.yahoo.com logoAKORN INC Financials (NASDAQ:AKRX)
finance.yahoo.com - August 12 at 3:35 PM
capitalcube.com logoAkorn, Inc. breached its 50 day moving average in a Bearish Manner : AKRX-US : August 11, 2016 (NASDAQ:AKRX)
www.capitalcube.com - August 11 at 12:38 PM
capitalcube.com logoETF’s with exposure to Akorn, Inc. : August 9, 2016 (NASDAQ:AKRX)
www.capitalcube.com - August 9 at 4:27 PM
capitalcube.com logoAkorn, Inc. :AKRX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 (NASDAQ:AKRX)
www.capitalcube.com - August 8 at 3:27 PM
fidaily.com logoWilliam Blair Investment Management, LLC Bought A Little More Akorn, Inc. (AKRX) Stock Last Quarter - Finance Daily (NASDAQ:AKRX)
www.fidaily.com - August 8 at 8:12 AM
News IconAnalysts Take on Akorn, Inc. (NASDAQ:AKRX) Rating - Post Registrar (NASDAQ:AKRX)
postregistrar.com - August 6 at 3:31 PM
equities.com logoAkorn Inc. (AKRX) Drops 5.36% on August 04 (NASDAQ:AKRX)
www.equities.com - August 6 at 11:09 AM
fortune.com logoA Look At Analyst Ratings Summary: Akorn, Inc. (NASDAQ:AKRX), Gramercy Property Trust (NYSE:GPT) - Review Fortune (NASDAQ:AKRX)
reviewfortune.com - August 5 at 8:48 PM
equities.com logoAkorn Inc. (AKRX) Drops 5.36% on August 04 - Equities.com (NASDAQ:AKRX)
www.equities.com - August 5 at 8:48 PM
thestreet.com logoAkorn (AKRX) Stock Drops Despite Q2 Beat (NASDAQ:AKRX)
www.thestreet.com - August 4 at 3:28 PM
marketwatch.com logoAkorn sets new stock buyback program, beats profit and sales expectations (NASDAQ:AKRX)
www.marketwatch.com - August 4 at 11:56 AM
nasdaq.com logoAkorn Inc Q2 Earnings Rise 41% (NASDAQ:AKRX)
www.nasdaq.com - August 4 at 11:56 AM
twst.com logoAkorn Inc.: Akorn Provides Second Quarter 2016 Results (NASDAQ:AKRX)
www.twst.com - August 4 at 11:56 AM
sg.finance.yahoo.com logoAkorn tops Street 2Q forecasts (NASDAQ:AKRX)
sg.finance.yahoo.com - August 4 at 11:56 AM
biz.yahoo.com logoAkorn Inc Earnings Call scheduled for 10:00 am ET today (NASDAQ:AKRX)
biz.yahoo.com - August 4 at 11:56 AM
feeds.reuters.com logoBRIEF-Akorn reported Q2 EPS $0.50 (NASDAQ:AKRX)
feeds.reuters.com - August 4 at 8:03 AM
fidaily.com logoAkorn, Inc. (AKRX) Investment Decreased by California Public Employees Retirement System - Finance Daily (NASDAQ:AKRX)
www.fidaily.com - August 3 at 9:03 PM
marketrealist.com logoHow Critical Is Valeant’s Pipeline to Its Success? (NASDAQ:AKRX)
marketrealist.com - August 3 at 3:29 PM
finance.yahoo.com logoAkorn downgraded by Raymond James (NASDAQ:AKRX)
finance.yahoo.com - August 2 at 3:24 PM
streetupdates.com logoAnalysts Ranking Previews: Mast Therapeutics, Inc. (NYSEMKT:MSTX) , Akorn, Inc. (NASDAQ:AKRX) - Street Updates (NASDAQ:AKRX)
www.streetupdates.com - July 26 at 3:26 PM
istreetwire.com logoStocks Alert: Mack-Cali Realty Corp. (CLI), Akorn, Inc. (AKRX), Plug Power Inc. (PLUG) - iStreetWire (NASDAQ:AKRX)
istreetwire.com - July 23 at 3:24 PM
News IconStock Up Nicely This Week: Akorn, Inc. (NASDAQ:AKRX) - TGP (NASDAQ:AKRX)
telanaganapress.com - July 23 at 3:24 PM
News IconStock Performance Rundown on Akorn, Inc. (NASDAQ:AKRX) - Engelwood Daily (NASDAQ:AKRX)
www.engelwooddaily.com - July 23 at 3:24 PM
News IconTwin Securities INC Increased Akorn INC (NASDAQ:AKRX) by $48.70 Million as Shares Declined - Press Telegraph (NASDAQ:AKRX)
presstelegraph.com - July 23 at 7:52 AM
News IconFriday Session Wrap-up for Akorn, Inc. (NASDAQ:AKRX) - Engelwood Daily (NASDAQ:AKRX)
www.engelwooddaily.com - July 22 at 8:25 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Akorn, Inc. (NASDAQ:AKRX) - TGP (NASDAQ:AKRX)
telanaganapress.com - July 22 at 3:24 PM
News IconAttention Grasping Stock With Upward Momentum: Akorn, Inc. (NASDAQ:AKRX) - TGP (NASDAQ:AKRX)
telanaganapress.com - July 22 at 3:24 PM
News IconMarket Minute - Focus on Akorn, Inc. (NASDAQ:AKRX) Stock - TGP (NASDAQ:AKRX)
telanaganapress.com - July 21 at 3:24 PM
News IconHigh Expectations Remain For Akorn, Inc. (NASDAQ:AKRX) - TGP (NASDAQ:AKRX)
telanaganapress.com - July 21 at 3:24 PM
finance.yahoo.com logoAkorn Announces Second Quarter 2016 Earnings Release and Conference Call Information (NASDAQ:AKRX)
finance.yahoo.com - July 21 at 8:05 AM
News IconShares Positive Over the Past Month: Akorn, Inc. (NASDAQ:AKRX) - TGP (NASDAQ:AKRX)
telanaganapress.com - July 20 at 10:51 PM
News IconStock Strength in Focus for Akorn, Inc. (NASDAQ:AKRX) - Press Telegraph (NASDAQ:AKRX)
presstelegraph.com - July 20 at 10:51 PM
News IconEquity Roundup: Stock Performance Focus on Akorn, Inc. (NASDAQ:AKRX) - Press Telegraph (NASDAQ:AKRX)
presstelegraph.com - July 19 at 3:25 PM
News IconLong Term Value Play: Akorn, Inc. (NASDAQ:AKRX) - TGP (NASDAQ:AKRX)
telanaganapress.com - July 19 at 3:25 PM


Akorn (NASDAQ:AKRX) Chart for Sunday, August, 28, 2016

Last Updated on 8/28/2016 by MarketBeat.com Staff